Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
36.31
+0.11 (0.30%)
May 14, 2025, 10:59 AM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Total Products | 2.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Products Growth | 60.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EXONDYS 51 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EXONDYS 51 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| VYONDYS 53 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| VYONDYS 53 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total PMO Products | 978.16M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total PMO Products Growth | 4.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Collaboration and Other | 193.37M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Collaboration and Other Growth | 48.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMONDYS 45 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMONDYS 45 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ELEVIDYS | 1.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ELEVIDYS Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|